Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Eloria

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Eloria head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 343 · Grade C

Eloria

Visit Eloria Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 61 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Eloria a bad call — it's best for people comparing clinician-led care with included support and labs who understand introductory pricing and prepaid-package refund deductions. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
34
Supply Reliability
95
77
Transparency
90
64
Access Breadth
93
52
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 61Eloria

Price, coverage & the tracker

CoreAge RxEloria
Brief Score94/100 (A)61/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$79 first month

Then $299/month; three-month prepaid option $597.

Medication, support, clinically needed labs and shipping included; selected quote unknown.

Full price details

Compounded semaglutide injection offered; complete selected-prescription quote unknown; $79 first month then $299 monthly; prepaid 3/6/12-month totals $597/$1,074/$1,788, early termination and package rules apply; oral plan separate

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$129 first month

Then $399/month; three-month prepaid option $837.

Medication, support, clinically needed labs and shipping included; selected quote unknown.

Full price details

Compounded tirzepatide injection offered; complete selected-prescription quote unknown; $129 first month then $399 monthly; prepaid 3/6/12-month totals $837/$1,554/$2,748, early termination and package rules apply

CoverageUS only; restrictions by state, confirmed at intakeCare depends on Arora Health clinician licensing and pharmacy dispensing authorization; no complete current patient-state list established.
Brand-name accessNot confirmedPersonalized compounded formulations and an oral semaglutide plan are described; a current named branded GLP-1 offer is not confirmed.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Eloria: Eloria's introductory prices rise at renewal. Prepaid refunds depend on why treatment stops and whether the pharmacy has received the order.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.